Every wake-up of this agent: what it saw, what it decided, what the validator rejected.
Requires the deployment's CRON_SECRET. Runs only this agent: gathers market data, asks its model for decisions, executes valid ones, and logs everything below. Can take a minute.
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 429: <!DOCTYPE html> <!--[if lt IE 7]> <html class="no-js ie6 oldie" lang="en-US"> <![endif]--> <!--[if IE 7]> <html class="no-js ie7 oldie" lang="en-US"> <![endif]--> <!--[if IE 8]> <html class="no-js ie8 oldie" lang="en-US"> <![endif]--> <!--[if gt IE 8]><!--> <html class="no-js" lang="en-US">
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: upstream 404 ({\"error\":{\"message\":\"0 endpoints out of 32 requested are available matching your guardrail restrictions and data policy. We removed them for the following reasons (an endpoint may have matched multiple reasons):\\nModel blocked by guard
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: upstream 404 ({\"error\":{\"message\":\"No allowed providers are available for the selected model. Providers serving z-ai/glm-5.2-20260616: streamlake, deepinfra, ambient, novita, digitalocean, coreweave, atlas-cloud, alibaba, siliconflow, inceptron, phal
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"This request requires more credits, or fewer max_tokens. You requested up to 6000 tokens, but can only afford 431. To increase, visit https://openrouter.ai/settings/credits and add more credits\",\"code\":402
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"This request requires more credits, or fewer max_tokens. You requested up to 6000 tokens, but can only afford 269. To increase, visit https://openrouter.ai/settings/credits and add more credits\",\"code\":402
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"This request requires more credits, or fewer max_tokens. You requested up to 6000 tokens, but can only afford 0. To increase, visit https://openrouter.ai/workspaces/default/keys/24fa1c9cb580e7a4b3a24e8d28cee7
S&P 500 sits in a strong uptrend at 95% of its 52-week range but a hotter-than-expected jobs report is pressuring bonds and complicating the rate-cut path into a seasonally difficult September. The tape is risk-on but late-cycle; selectivity matters more than aggression today.
Book is 40.5% deployed across three green positions (ABT +9.9%, NU +10.8%, SMCI +22.8%), all with intact theses and no stops triggered. NU is marginally over the 15% cap at 15.2% due to appreciation, but since no trade is being placed on NU this run, no violation occurs. Concentration risk is moderate; the biggest threat would be a sharp AI-infrastructure de-risking hitting SMCI, which is approaching the +25% profit-review line.
SMCI at +22.75% — next run if it crosses +25%, explicitly evaluate trimming 1 share to lock gains and free capital; watch for the shareholder sale and $6.8B cash outflow headlines to weigh on price. NU investor day Dec 8 is a catalyst to hold for; watch for any pullback below $14.50 as an invalidation signal. ABT is steady in a healthcare-safe haven role; no action needed unless it breaks below $104 (50-day vicinity). The affordable candidate universe today is dominated by extended day-gainers (PURR, BULL, XXI, HSAI) and falling knives (PL, TSN, PSQL) — neither meets the entry checklist. Re-scan next run for pullback setups in quality names.
{"market_summary":"S&P 500 sits in a strong uptrend at 95% of its 52-week range but a hotter-than-expected jobs report is pressuring bonds and complicating the rate-cut path into a seasonally difficult September. The tape is risk-on but late-cycle; selectivity matters more than aggression today.","risk_assessment":"Book is 40.5% deployed across three green positions (ABT +9.9%, NU +10.8%, SMCI +22.8%), all with intact theses and no stops triggered. NU is marginally over the 15% cap at 15.2% due to appreciation, but since no trade is being placed on NU this run, no violation occurs. Concentration risk is moderate; the biggest threat would be a sharp AI-infrastructure de-risking hitting SMCI, which is approaching the +25% profit-review line.","decisions":[],"watch_notes":"SMCI at +22.75% — next run if it crosses +25%, explicitly evaluate trimming 1 share to lock gains and free capital; watch for the shareholder sale and $6.8B cash outflow headlines to weigh on price. NU investor day Dec 8 is a catalyst to hold for; watch for any pullback below $14.50 as an invalidation signal. ABT is steady in a healthcare-safe haven role; no action needed unless it breaks below $104 (50-day vicinity). The affordable candidate universe today is dominated by extended day-gainers (PURR, BULL, XXI, HSAI) and falling knives (PL, TSN, PSQL) — neither meets the entry checklist. Re-scan next run for pullback setups in quality names.","consult_request":null}LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
Market news feed unavailable — reasoning from price data alone.
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
Market news feed unavailable — reasoning from price data alone.
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"This request requires more credits, or fewer max_tokens. You requested up to 6000 tokens, but can only afford 0. To increase, visit https://openrouter.ai/settings/credits and add more credits\",\"code\":402,\
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
60.5% cash, three positions, none breached invalidations. SMCI is the largest risk (14.5%, ATR 6.3%, +18.3%) and is the one approaching the +25% trim line; ABT and NU are benign. Biggest threat to the book is a continued yield-driven squeeze on SMCI.
SMCI: trim-review triggers at +25% (~$39/share) or exit on daily close below ~$33. ABT: revisit if it tags 52-week support or breaks $103; trim consideration above +25% (~$124, unlikely near-term). NU: exit below $13.50. Cash deployment triggers: a genuine risk-on day (semis leading with breadth) would justify redeploying toward a quality pullback name — not today. Watching PS ($38.94, uptrend, -9.3% today) as a candidate mean-reversion entry only if it stabilizes rather than continuing to break down.
{
"market_assessment": "September opens with a broad risk-off tape: global bond selloff, surging oil on renewed Iran strikes, and inflation fears pressuring equities. Semis and high-multiple tech are sliding on yields; leadership is defensive. This is a tape for patience and cash, not new exposure.",
"risk_assessment": "60.5% cash, three positions, none breached invalidations. SMCI is the largest risk (14.5%, ATR 6.3%, +18.3%) and is the one approaching the +25% trim line; ABT and NU are benign. Biggest threat to the book is a continued yield-driven squeeze on SMCI.",
"risk_review": [
{
"ticker": "ABT",
"action": "HOLD",
"reasoning": "+10% unrealized, uptrend intact, RSI 49, healthcare defensiveness is actually an asset in this risk-off tape. The 1W -6.2% pullback is modest against +25.3% over 3M. No invalidation hit. Let the winner run — my track record says I cut winners too early; this one has structure and sector tailwind. Will revisit trim above +25% or a break of the 50-day (~$103)."
},
{
"ticker": "SMCI",
"action": "HOLD",
"reasoning": "+18.3% unrealized, strong uptrend, +17.5% above the 50-day. The illegal-export-probe headline is concerning noise but unquantified, and the Cisco AI infrastructure deal supports the thesis. At +18% I'm below the +25% trim-review line; the momentum structure holds. Invalidation: daily close below ~$33 (50-day region) breaks the trend thesis and I exit fully. Volatility is high (ATR 6.3%), so I will not add here — position is already at effective full size."
},
{
"ticker": "NU",
"action": "HOLD",
"reasoning": "Choppy but +2.3%, RSI 51, holding above its 50-day with a fundamentally-supported 'undervalued on revenue beat' narrative. Small position (14.3%), thesis intact. Invalidation: close below ~$13.50 (50-day support zone). Nothing to do here."
}
],
"decisions": [],
"watch_notes": "SMCI: trim-review triggers at +25% (~$39/share) or exit on daily close below ~$33. ABT: revisit if it tags 52-week support or breaks $103; trim consideration above +25% (~$124, unlikely near-term). NU: exit below $13.50. Cash deployment triggers: a genuine risk-on day (semis leading with breadth) would justify redeploying toward a quality pullback name — not today. Watching PS ($38.94, uptrend, -9.3% today) as a candidate mean-reversion entry only if it stabilizes rather than continuing to break down.",
"consult_request": null
}LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"This request requires more credits, or fewer max_tokens. You requested up to 6000 tokens, but can only afford 0. To increase, visit https://openrouter.ai/workspaces/default/keys/24fa1c9cb580e7a4b3a24e8d28cee7
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: upstream 404 ({\"error\":{\"message\":\"No allowed providers are available for the selected model. Providers serving z-ai/glm-5.2-20260616: baidu, streamlake, deepinfra, sail-research, ambient, decart, digitalocean, inceptron, novita, coreweave, alibaba,
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"This request requires more credits, or fewer max_tokens. You requested up to 6000 tokens, but can only afford 0. To increase, visit https://openrouter.ai/settings/credits and add more credits\",\"code\":402,\
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
Tape is softening into the close as Warsh comments boost rate-hike expectations and yields rise — a mild de-risking tone following yesterday's NVDA-driven rally. S&P is still in an uptrend but breadth is narrowing; this is not a tape that rewards aggression.
Exposure is 50.3% across four positions, with ABT and SMCI both near the cap and both in profit. The biggest risk is PYPL: my mean-reversion thesis was predicated on 'no company-specific catalyst,' and headlines now confirm the Stripe takeover bid collapsed — a fundamental event, not technical liquidation. That invalidates the thesis and I must exit.
After this sale, cash rises to ~$614 (60%+). Book is ABT (11%), NU (14%), SMCI (14.6%) — all held. Watching: (1) SMCI approaching +25% trim line at ~$39.00; will trim if it tags that level. (2) NU on insider-sale overhang — if it breaks below $13.50 (recent support area) or closes below the 50-day, I will exit. (3) ABT thesis intact as a defensive quality hold; no action needed until either +25% or a trend break. (4) No new buys this run: regime is risk-cautious with rising yields, and nothing in the screener offers a high-conviction setup that isn't either extended (ESTC RSI 76) or lacking a clear catalyst. Patience here is the correct trade — a flat run with no blowups is the mandate.
{
"market_summary": "Tape is softening into the close as Warsh comments boost rate-hike expectations and yields rise — a mild de-risking tone following yesterday's NVDA-driven rally. S&P is still in an uptrend but breadth is narrowing; this is not a tape that rewards aggression.",
"risk_assessment": "Exposure is 50.3% across four positions, with ABT and SMCI both near the cap and both in profit. The biggest risk is PYPL: my mean-reversion thesis was predicated on 'no company-specific catalyst,' and headlines now confirm the Stripe takeover bid collapsed — a fundamental event, not technical liquidation. That invalidates the thesis and I must exit.",
"decisions": [
{
"action": "SELL",
"ticker": "PYPL",
"shares": 2,
"conviction": "HIGH",
"thesis": "Thesis invalidated: the original buy was predicated on PYPL's drop having no company-specific catalyst; headlines now confirm the Stripe takeover bid collapsed, making this a fundamental re-rating, not overdone technical selling.",
"invalidation": "Already triggered — deal-collapse news is the fundamental catalyst my thesis explicitly assumed did not exist. Price is also clinging to the 50-day (~$53.80) on 2.1x volume, meeting the second invalidation criterion.",
"reasoning": "My standing thesis stated the drop was 'on no company-specific negative catalyst.' Barron's and CNBC now report the Stripe takeover bid collapsed — that is the definition of a company-specific fundamental catalyst. The entire premise of the mean-reversion trade is gone: this isn't overdone institutional liquidation, it's the market re-pricing PYPL as a standalone asset after a deal premium was removed. My invalidation criteria were a close below the 50-day or a second consecutive down day on above-average volume without a base; PYPL is at $54.02 with the 50-day near $53.80, on 2.1x volume, day two of the decline. Both thresholds are effectively met. The track-record warning says I hold losers too long — this is exactly the moment to stop doing that. Exit immediately, no negotiation."
}
],
"watch_notes": "After this sale, cash rises to ~$614 (60%+). Book is ABT (11%), NU (14%), SMCI (14.6%) — all held. Watching: (1) SMCI approaching +25% trim line at ~$39.00; will trim if it tags that level. (2) NU on insider-sale overhang — if it breaks below $13.50 (recent support area) or closes below the 50-day, I will exit. (3) ABT thesis intact as a defensive quality hold; no action needed until either +25% or a trend break. (4) No new buys this run: regime is risk-cautious with rising yields, and nothing in the screener offers a high-conviction setup that isn't either extended (ESTC RSI 76) or lacking a clear catalyst. Patience here is the correct trade — a flat run with no blowups is the mandate.",
"consult_request": null
}S&P in strong uptrend near 52-week highs, but Warsh's Jackson Hole comments are lifting rate-hike bets and yields—creating a tension between AI-driven earnings optimism (NVDA blowout) and macro headwinds. Breadth is mixed with software/AI names roaring while rate-sensitive and speculative names sell off. This is a risk-on but selective tape; new exposure should favor quality pullbacks over chasing extended movers.
Book is 40% deployed across 3 positions, 60% cash—well-capitalized and under-levered. ABT and SMCI are both in healthy uptrends with intact theses; SMCI at +22% is approaching the +25% trim review line but hasn't triggered. NU is choppy and flat—small position, low concern. Biggest risk is the track-record pattern of cutting winners early; discipline today means letting ABT and SMCI run unless invalidations hit.
SMCI at +22.4%—watch for +25% trim trigger next run; if it tags $39.50+ consider trimming 1 share to lock gains while letting the remainder run. ABT uptrend intact, no action needed unless it breaks below $108 (50-day proximity). NU choppy and flat—if it closes below $13.50, thesis weakens. PYPL: watch for stabilization/bounce tomorrow; if it gaps down again on heavy volume, exit immediately. Macro: Warsh rate-hike rhetoric could pressure multiple expansion names—stay defensive on new adds.
{
"market_summary": "S&P in strong uptrend near 52-week highs, but Warsh's Jackson Hole comments are lifting rate-hike bets and yields—creating a tension between AI-driven earnings optimism (NVDA blowout) and macro headwinds. Breadth is mixed with software/AI names roaring while rate-sensitive and speculative names sell off. This is a risk-on but selective tape; new exposure should favor quality pullbacks over chasing extended movers.",
"risk_assessment": "Book is 40% deployed across 3 positions, 60% cash—well-capitalized and under-levered. ABT and SMCI are both in healthy uptrends with intact theses; SMCI at +22% is approaching the +25% trim review line but hasn't triggered. NU is choppy and flat—small position, low concern. Biggest risk is the track-record pattern of cutting winners early; discipline today means letting ABT and SMCI run unless invalidations hit.",
"decisions": [
{
"action": "BUY",
"ticker": "PYPL",
"shares": 2,
"conviction": "MEDIUM",
"thesis": "Oversold mean-reversion: PYPL down 11.5% today on no company-specific negative catalyst, RSI 37, yet still above its 50-day and up 21.6% over 3 months—the uptrend is intact and today's flush looks like an overdone institutional liquidation.",
"invalidation": "A close below the 50-day moving average (currently ~$53.80 area given +1.1% vs 50d at $54.42), or a second consecutive down day on above-average volume without a base forming—either signals the selling is fundamental, not technical.",
"reasoning": "PYPL fits the mean-reversion setup: a quality fintech name in a confirmed uptrend (above 50-day, +21.6% over 3 months) that is getting hammered today on no stock-specific news. The 11.5% drop on 1.7x average volume suggests forced selling or index rebalancing rather than a thesis change. RSI at 37 is oversold but not capitulation-oversold, leaving room for a bounce. I am buying 2 shares ($108.84, ~10.6% of equity) as a half-cap medium-conviction position—sized down for the 3.6% ATR volatility. This is not averaging down into a broken thesis; it is a new position entering on a dislocation. The key discipline is the invalidation: if PYPL closes below its 50-day, the uptrend thesis is voided and I exit without negotiation. I am deliberately avoiding the day-gainers list (ESTC +17.6%, AFRM +8.1%) because those moves are already priced in and RSI extensions (77, 63 respectively) create reversal risk. With 60% cash and only 3 positions, deploying into a quality pullback is the right use of capital without overtrading."
}
],
"watch_notes": "SMCI at +22.4%—watch for +25% trim trigger next run; if it tags $39.50+ consider trimming 1 share to lock gains while letting the remainder run. ABT uptrend intact, no action needed unless it breaks below $108 (50-day proximity). NU choppy and flat—if it closes below $13.50, thesis weakens. PYPL: watch for stabilization/bounce tomorrow; if it gaps down again on heavy volume, exit immediately. Macro: Warsh rate-hike rhetoric could pressure multiple expansion names—stay defensive on new adds.",
"consult_request": null
}LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"This request requires more credits, or fewer max_tokens. You requested up to 6000 tokens, but can only afford 12. To increase, visit https://openrouter.ai/settings/credits and add more credits\",\"code\":402,
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
LLM call failed: LLM HTTP 402: {"error":{"code":null,"message":"openrouter: out of credit (402) ({\"error\":{\"message\":\"Insufficient credits. Add more using https://openrouter.ai/settings/credits\",\"code\":402,\"metadata\":{\"limit_source\":\"openrouter_credits\",\"remedy_hint\":\"Add credits at https://openrouter.ai/settings
Tape is flat-to-lower into the close, with investors de-risking ahead of tonight's Nvidia earnings and a hotter PCE print. Bond yields are rising, adding a headwind to duration-sensitive names. This is a wait-and-see regime, not a risk-on tape to press new exposure into.
Book is 40% deployed across three uptrending positions (ABT, NU, SMCI), all green, with 60% cash. Concentration is moderate — each position is 11-15% of equity. The biggest risk tonight is a binary NVDA outcome that gaps semiconductors and risk assets broadly; my SMCI exposure is the most vulnerable to that, but its thesis (momentum, oversold rebound) is intact and RSI is neutral at 59.
Holding all three positions into NVDA earnings. ABT at +15.5% — let it run toward the +25% trim line rather than cutting early (per track-record warning). SMCI at +19.9% — watch for a close below $34 (50-day proximity) as invalidation; if it tags +25% post-NVDA, trim one share to lock gains. NU steady, no action needed. If NVDA beats and risk-on resumes Thursday, I'll look at FIGR or SYRE pullbacks as mean-reversion setups; if NVDA disappoints, I reassess SMCI first thing. Cash stays dry tonight.
{
"market_summary": "Tape is flat-to-lower into the close, with investors de-risking ahead of tonight's Nvidia earnings and a hotter PCE print. Bond yields are rising, adding a headwind to duration-sensitive names. This is a wait-and-see regime, not a risk-on tape to press new exposure into.",
"risk_assessment": "Book is 40% deployed across three uptrending positions (ABT, NU, SMCI), all green, with 60% cash. Concentration is moderate — each position is 11-15% of equity. The biggest risk tonight is a binary NVDA outcome that gaps semiconductors and risk assets broadly; my SMCI exposure is the most vulnerable to that, but its thesis (momentum, oversold rebound) is intact and RSI is neutral at 59.",
"decisions": [],
"watch_notes": "Holding all three positions into NVDA earnings. ABT at +15.5% — let it run toward the +25% trim line rather than cutting early (per track-record warning). SMCI at +19.9% — watch for a close below $34 (50-day proximity) as invalidation; if it tags +25% post-NVDA, trim one share to lock gains. NU steady, no action needed. If NVDA beats and risk-on resumes Thursday, I'll look at FIGR or SYRE pullbacks as mean-reversion setups; if NVDA disappoints, I reassess SMCI first thing. Cash stays dry tonight.",
"consult_request": null
}Tape is drifting lower on hot inflation data and rising bond yields, with the real event risk still ahead — NVDA earnings tonight. S&P structure remains an uptrend but today is a de-risking pause, not a risk-on tape. Abercrombie's 32% gap on earnings is the only real heat; breadth is thin. This is a day to protect capital, not chase.
Book is 52% exposed across four names, all in uptrends, with NU and SMCI near the 15% cap. The biggest risk is BEAM — my momentum-continuation thesis has stalled, the stock is down 3.3% today and sitting only +0.4% above its 50-day, one bad session from invalidation. SMCI at +21.5% is approaching the trim-review line but the trend is strong and RSI is only 60; premature trimming is exactly the failure mode my track record flags.
Watching SMCI into NVDA earnings tonight — a strong NVDA print could extend SMCI's AI-hardware momentum toward the +25% trim line; a weak print risks a gap-down through the 50d and I'll reassess sizing next run. ABT at RSI 70 is getting extended; if it tags +25% I'll trim to lock gains. NU remains the cleanest trend in the book, holding. Cash will be roughly 59% post-BEAM sale, which is the right posture into tonight's event — I'd rather deploy Thursday morning with clarity than hold fresh risk into NVDA.
{
"market_summary": "Tape is drifting lower on hot inflation data and rising bond yields, with the real event risk still ahead — NVDA earnings tonight. S&P structure remains an uptrend but today is a de-risking pause, not a risk-on tape. Abercrombie's 32% gap on earnings is the only real heat; breadth is thin. This is a day to protect capital, not chase.",
"risk_assessment": "Book is 52% exposed across four names, all in uptrends, with NU and SMCI near the 15% cap. The biggest risk is BEAM — my momentum-continuation thesis has stalled, the stock is down 3.3% today and sitting only +0.4% above its 50-day, one bad session from invalidation. SMCI at +21.5% is approaching the trim-review line but the trend is strong and RSI is only 60; premature trimming is exactly the failure mode my track record flags.",
"decisions": [
{
"action": "SELL",
"ticker": "BEAM",
"shares": 4,
"conviction": "MEDIUM",
"thesis": "Momentum-continuation thesis has failed to materialize; stock is rolling over and one session from the 50d invalidation.",
"invalidation": "Already triggered in spirit: the continuation never happened and BEAM is now -3.3% on the day with only +0.4% of 50d cushion remaining.",
"reasoning": "My standing thesis on BEAM was explicit: momentum continuation with room to run, invalidated by a close below the 50-day. The stock is not yet below the 50-day, but the continuation thesis is clearly broken — BEAM has done nothing but fade since entry, it's down 3.3% today on no catalyst, and the 50d cushion has compressed from a comfortable margin to +0.4%. Waiting for the exact close-below-50d trigger risks a gap-down that blows through my stop. My track record explicitly warns me about holding losers too long, and this is a loser whose thesis is deteriorating, not a winner I'm cutting early. Exiting now frees ~$120 of capital and removes the weakest name from the book ahead of NVDA-event risk tonight. Discipline says act before the invalidation, not after."
}
],
"watch_notes": "Watching SMCI into NVDA earnings tonight — a strong NVDA print could extend SMCI's AI-hardware momentum toward the +25% trim line; a weak print risks a gap-down through the 50d and I'll reassess sizing next run. ABT at RSI 70 is getting extended; if it tags +25% I'll trim to lock gains. NU remains the cleanest trend in the book, holding. Cash will be roughly 59% post-BEAM sale, which is the right posture into tonight's event — I'd rather deploy Thursday morning with clarity than hold fresh risk into NVDA.",
"consult_request": null
}S&P is in a mild uptrend (RSI 54, +3.33% 1M) but pulling back slightly ahead of inflation data and NVDA earnings tonight. Bond yields are rising, adding risk to the tape. This is a wait-and-see environment — aggression should be low until NVDA clears or fails.
Exposure is 52.1% across 4 positions, all in confirmed uptrends. Concentration is reasonable with no position exceeding the 15% cap. BEAM is the primary risk — it sits just +0.3% above its 50-day MA and was down 3.3% today; a close below the 50d triggers my stated invalidation and an immediate exit. SMCI at +21.93% is approaching the +25% trim-review line and needs close monitoring.
BEAM: watching the 50-day MA closely — a close below ~$29.90 (current 50d level) triggers an immediate full exit next run. SMCI: at +21.93%, if it pushes above +25% I will trim 1-2 shares to lock gains and free capital. ABT and NU: theses intact, letting winners run per track-record correction. NVDA earnings tonight will set the tone for AI-adjacent names (SMCI, MU); a miss could pressure SMCI hard and I will reassess size immediately. No new buys this run — the candidate universe is either extended (ANF RSI 79, BZ RSI 73) or in downtrends, and the regime calls for patience.
{
"market_summary": "S&P is in a mild uptrend (RSI 54, +3.33% 1M) but pulling back slightly ahead of inflation data and NVDA earnings tonight. Bond yields are rising, adding risk to the tape. This is a wait-and-see environment — aggression should be low until NVDA clears or fails.",
"risk_assessment": "Exposure is 52.1% across 4 positions, all in confirmed uptrends. Concentration is reasonable with no position exceeding the 15% cap. BEAM is the primary risk — it sits just +0.3% above its 50-day MA and was down 3.3% today; a close below the 50d triggers my stated invalidation and an immediate exit. SMCI at +21.93% is approaching the +25% trim-review line and needs close monitoring.",
"decisions": [],
"watch_notes": "BEAM: watching the 50-day MA closely — a close below ~$29.90 (current 50d level) triggers an immediate full exit next run. SMCI: at +21.93%, if it pushes above +25% I will trim 1-2 shares to lock gains and free capital. ABT and NU: theses intact, letting winners run per track-record correction. NVDA earnings tonight will set the tone for AI-adjacent names (SMCI, MU); a miss could pressure SMCI hard and I will reassess size immediately. No new buys this run — the candidate universe is either extended (ANF RSI 79, BZ RSI 73) or in downtrends, and the regime calls for patience.",
"consult_request": null
}S&P in a strong uptrend but futures are soft on sticky inflation data and rising bond yields, with NVDA earnings after the close as the dominant event risk. This is a tape to respect, not to chase — adding beta ahead of a binary catalyst is gambling, not sizing.
Book is 52% deployed across four uptrending names, 48% cash, no position above 15%. All four theses are intact with no invalidations triggered. SMCI at +22% is approaching the +25% profit-review line and carries direct NVDA-earnings event risk tonight, but RSI 62 is not extended and the trend is clean. Biggest risk is a gap-down in SMCI on a NVDA miss; that is acceptable given position size.
HOLD run. Watching SMCI into NVDA earnings tonight — if it gaps below $34 (50-day region) tomorrow, trim to lock the +22% gain. ABT at RSI 75 is extended; a close below $110 would signal the run is exhausting and warrant a trim. BEAM invalidation remains a close below its 50-day (~$29.80); it is holding the trend so no action. NU is steady in a gentle uptrend, no action needed. If NVDA beats and risk-on resumes Thursday, I will look for one high-conviction add in the $31–$155 range; if NVDA misses, I raise cash defensively on any position that breaks its 50-day.
{
"market_summary": "S&P in a strong uptrend but futures are soft on sticky inflation data and rising bond yields, with NVDA earnings after the close as the dominant event risk. This is a tape to respect, not to chase — adding beta ahead of a binary catalyst is gambling, not sizing.",
"risk_assessment": "Book is 52% deployed across four uptrending names, 48% cash, no position above 15%. All four theses are intact with no invalidations triggered. SMCI at +22% is approaching the +25% profit-review line and carries direct NVDA-earnings event risk tonight, but RSI 62 is not extended and the trend is clean. Biggest risk is a gap-down in SMCI on a NVDA miss; that is acceptable given position size.",
"decisions": [],
"watch_notes": "HOLD run. Watching SMCI into NVDA earnings tonight — if it gaps below $34 (50-day region) tomorrow, trim to lock the +22% gain. ABT at RSI 75 is extended; a close below $110 would signal the run is exhausting and warrant a trim. BEAM invalidation remains a close below its 50-day (~$29.80); it is holding the trend so no action. NU is steady in a gentle uptrend, no action needed. If NVDA beats and risk-on resumes Thursday, I will look for one high-conviction add in the $31–$155 range; if NVDA misses, I raise cash defensively on any position that breaks its 50-day.",
"consult_request": null
}Risk-on tape recovering into NVDA earnings and Jackson Hole, with S&P near its 52-week high and breadth improving. Oil selling off and Bitcoin at $80K signal liquidity-friendly conditions, but the catalyst wall ahead warrants patience rather than reaching into extended day-gainers.
Book is 52.4% deployed across four uptrending positions, all with RSI in the 60-76 range and intact structure. Concentration is moderate with no position above 15%. Biggest risk is ABT at RSI 76 — extended but supported by a fresh catalyst. SMCI at +22.9% is approaching the +25% profit-review line and warrants close monitoring next run.
SMCI: approaching +25% profit-review at $39.50 (cost $31.17 × 1.25); if it tags that level, trim 1 share to lock gains. ABT: RSI 76 is extended — if it closes below its 5-day or RSI rolls under 70, consider trimming. BEAM: second 10% surge in two sessions — watch for RSI pushing above 70 which would shift it from momentum-continuation to extended. NU: cleanest structure in the book, holding as core. No new buys today — every affordable candidate is either extended (ABCL RSI 74, PURR RSI 84, RUM RSI 83, GENB RSI 76) or in a downtrend (DKS, OKLO, MAIR). Re-evaluate post-NVDA earnings for dislocations and rotation opportunities.
{
"market_summary": "Risk-on tape recovering into NVDA earnings and Jackson Hole, with S&P near its 52-week high and breadth improving. Oil selling off and Bitcoin at $80K signal liquidity-friendly conditions, but the catalyst wall ahead warrants patience rather than reaching into extended day-gainers.",
"risk_assessment": "Book is 52.4% deployed across four uptrending positions, all with RSI in the 60-76 range and intact structure. Concentration is moderate with no position above 15%. Biggest risk is ABT at RSI 76 — extended but supported by a fresh catalyst. SMCI at +22.9% is approaching the +25% profit-review line and warrants close monitoring next run.",
"decisions": [],
"watch_notes": "SMCI: approaching +25% profit-review at $39.50 (cost $31.17 × 1.25); if it tags that level, trim 1 share to lock gains. ABT: RSI 76 is extended — if it closes below its 5-day or RSI rolls under 70, consider trimming. BEAM: second 10% surge in two sessions — watch for RSI pushing above 70 which would shift it from momentum-continuation to extended. NU: cleanest structure in the book, holding as core. No new buys today — every affordable candidate is either extended (ABCL RSI 74, PURR RSI 84, RUM RSI 83, GENB RSI 76) or in a downtrend (DKS, OKLO, MAIR). Re-evaluate post-NVDA earnings for dislocations and rotation opportunities.",
"consult_request": null
}Tape is modestly risk-on into NVDA earnings and Jackson Hole — S&P flat-to-slightly-green, yields falling, chips leading. But VIX curve anxiety and a gainer list full of 10%+ movers that are already extended suggest this is a chase-tape, not a clean entry environment. Capital preservation into event risk is the right posture.
Book is 52% invested across 4 names, 48% cash — well-positioned for event risk. SMCI at +22.55% is approaching the +25% profit-review line and ABT at +16.79% with RSI 73 is getting extended; both need close monitoring. BEAM and NU are constructive but not yet at review thresholds. Biggest risk is a NVDA-earnings gap dragging SMCI, though SMCI's move today (+8.6%) shows it's trading on its own dynamics.
SMCI: trim trigger at +25% unrealized (~$39.00) — if it tags that level, sell 2 shares to lock gains and free capital. ABT: RSI 73 and up 33% in 3 months — if it closes below its 5-day or RSI breaks below 65, consider exiting the single share. BEAM: invalidation remains a close below the 50-day (~$29.90); +10% today is strong but RSI 61 leaves room. NU: choppy but holding above 50-day; no action needed unless it breaks $14.00. No new buys this run — every affordable name on the gainer list is either RSI >70, up double digits today, or in a downtrend. Waiting for a setup rather than forcing one into NVDA event risk.
{
"market_summary": "Tape is modestly risk-on into NVDA earnings and Jackson Hole — S&P flat-to-slightly-green, yields falling, chips leading. But VIX curve anxiety and a gainer list full of 10%+ movers that are already extended suggest this is a chase-tape, not a clean entry environment. Capital preservation into event risk is the right posture.",
"risk_assessment": "Book is 52% invested across 4 names, 48% cash — well-positioned for event risk. SMCI at +22.55% is approaching the +25% profit-review line and ABT at +16.79% with RSI 73 is getting extended; both need close monitoring. BEAM and NU are constructive but not yet at review thresholds. Biggest risk is a NVDA-earnings gap dragging SMCI, though SMCI's move today (+8.6%) shows it's trading on its own dynamics.",
"decisions": [],
"watch_notes": "SMCI: trim trigger at +25% unrealized (~$39.00) — if it tags that level, sell 2 shares to lock gains and free capital. ABT: RSI 73 and up 33% in 3 months — if it closes below its 5-day or RSI breaks below 65, consider exiting the single share. BEAM: invalidation remains a close below the 50-day (~$29.90); +10% today is strong but RSI 61 leaves room. NU: choppy but holding above 50-day; no action needed unless it breaks $14.00. No new buys this run — every affordable name on the gainer list is either RSI >70, up double digits today, or in a downtrend. Waiting for a setup rather than forcing one into NVDA event risk.",
"consult_request": null
}S&P in strong uptrend near 52-week highs but chip momentum fading into NVDA earnings tomorrow; VIX curve shows growing anxiety. Risk-on but cautious tape — not the moment to chase extended day-gainers, and a flat-to-defensive posture ahead of a binary catalyst is prudent.
Three positions all green, 59.8% cash, no concentration breaches. SMCI at +22.84% is approaching the +25% profit-review line and is the main risk — a negative NVDA print tomorrow could reverse the AI-server trade quickly. ABT is a steady defensive winner; NU is early in its thesis.
SMCI: if it crosses +25% unrealized ($38.96+), trim 1 share to lock gains and reduce NVDA-earnings binary risk. ABT: hold through uptrend, RSI 72 is elevated but not a sell signal in a trending name. NU: watch for a close below $14.00 as early invalidation. BEAM: watch 50-day and RSI — if RSI exceeds 75 on a continuation move, take profits.
{ "market_summary": "S&P in strong uptrend near 52-week highs but chip momentum fading into NVDA earnings tomorrow; VIX curve shows growing anxiety. Risk-on but cautious tape — not the moment to chase extended day-gainers, and a flat-to-defensive posture ahead of a binary catalyst is prudent.", "risk_assessment": "Three positions all green, 59.8% cash, no concentration breaches. SMCI at +22.84% is approaching the +25% profit-review line and is the main risk — a negative NVDA print tomorrow could reverse the AI-server trade quickly. ABT is a steady defensive winner; NU is early in its thesis.", "decisions": [ { "action": "BUY", "ticker": "BEAM", "shares": 4, "conviction": "MEDIUM", "thesis": "Gene-editing momentum name in a confirmed uptrend, RSI 61 (not extended), pulling back from a 10% day move — momentum continuation with room to run.", "invalidation": "Close below the 50-day moving average, which would break the uptrend structure and signal the move is over.", "reasoning": "BEAM fits the momentum checklist: price above 50-day (+4.4%) and 200-day (+10.7%), RSI at 61 is well below the 75 caution zone, and the stock is up 24.7% over the past month without becoming parabolic. Today's +10.3% move is notable but below the 15% chase threshold, and ATR of 5.5% is moderate for a biotech. The gene-editing space has been quietly strong and BEAM offers exposure without the extreme extension seen in names like RUM (RSI 83) or PURR (RSI 83). I am sizing at roughly 12% of equity — half the cap reflects MEDIUM conviction and the higher volatility of a small-cap biotech. With NVDA earnings tomorrow creating binary risk across the tape, I prefer a thesis uncorrelated to the AI-chip narrative. Cash remains well above the 5% floor after this purchase." } ], "watch_notes": "SMCI: if it crosses +25% unrealized ($38.96+), trim 1 share to lock gains and reduce NVDA-earnings binary risk. ABT: hold through uptrend, RSI 72 is elevated but not a sell signal in a trending name. NU: watch for a close below $14.00 as early invalidation. BEAM: watch 50-day and RSI — if RSI exceeds 75 on a continuation move, take profits.", "consult_request": null }S&P 500 is in a strong uptrend near its 52-week high, but the tape is bifurcated: chip stocks are selling off ahead of Nvidia earnings Wednesday while software and select momentum names catch bids. This is a sector rotation, not a broad de-risking, but the catalyst risk around NVDA makes new entries in semis or AI-adjacent names premature.
Book is 39.5% deployed across three positions, 60.5% cash — well-capitalized and unconcentrated enough to absorb a bad day. ABT at RSI 78 is the most extended risk; SMCI's -5.56% day on chip weakness is the most active threat. No position is below the -12% stop line. The main risk is that a disappointing NVDA print Wednesday drags SMCI through its 50-day and spills into broader risk sentiment.
ABT: RSI 78, +17.84% — approaching the +25% profit-review line; if it stalls below $118 for 2 sessions, trim to lock gains. SMCI: watching the 50-day (~$30.50) as the invalidation level; a close below it on the back of a weak NVDA print means exit. NU: holding fine, choppy but above cost basis; no action needed unless it breaks below $14.00. Post-NVDA earnings Wednesday, I will re-evaluate deploying cash into either a confirmed chip recovery or a software momentum continuation. EZPW and SA are on the radar as momentum candidates if they pull back from today's extended moves.
{
"market_summary": "S&P 500 is in a strong uptrend near its 52-week high, but the tape is bifurcated: chip stocks are selling off ahead of Nvidia earnings Wednesday while software and select momentum names catch bids. This is a sector rotation, not a broad de-risking, but the catalyst risk around NVDA makes new entries in semis or AI-adjacent names premature.",
"risk_assessment": "Book is 39.5% deployed across three positions, 60.5% cash — well-capitalized and unconcentrated enough to absorb a bad day. ABT at RSI 78 is the most extended risk; SMCI's -5.56% day on chip weakness is the most active threat. No position is below the -12% stop line. The main risk is that a disappointing NVDA print Wednesday drags SMCI through its 50-day and spills into broader risk sentiment.",
"decisions": [],
"watch_notes": "ABT: RSI 78, +17.84% — approaching the +25% profit-review line; if it stalls below $118 for 2 sessions, trim to lock gains. SMCI: watching the 50-day (~$30.50) as the invalidation level; a close below it on the back of a weak NVDA print means exit. NU: holding fine, choppy but above cost basis; no action needed unless it breaks below $14.00. Post-NVDA earnings Wednesday, I will re-evaluate deploying cash into either a confirmed chip recovery or a software momentum continuation. EZPW and SA are on the radar as momentum candidates if they pull back from today's extended moves.",
"consult_request": null
}Mild risk-off session with semis under pressure ahead of NVDA earnings and geopolitical noise from Iran sanctions; S&P holding its uptrend but breadth is soft. My book is well-positioned with three profitable holdings and 60% cash — no need to force activity into a tape that isn't offering a clean setup.
Three positions, all green, all within size limits, cash at 60.5%. Biggest risk is SMCI's compliance headline drag — it's down 5.2% today and the Taiwan export story could escalate. ABT at RSI 75 is hot but the trend is strong and I'm not trimming a winner early given my track-record problem. No position is below its stop line.
HOLD run — no clean entry in the affordable universe without chasing. SMCI: thesis intact while above 50-day (~$30.50); if the Taiwan export compliance story escalates or price closes below the 50-day, exit immediately. ABT: let it run toward +25% (~$123.76) before considering a trim; RSI 75 is hot but trend supports it. NU: hold unless it breaks below $13.80 (recent support area). HIMS ($30.94) is a potential mean-reversion candidate if it gets more oversold (RSI < 40) with a clearer catalyst — not there yet. Watching NVDA earnings as a directional catalyst for the entire semi complex including SMCI.
```json
{
"market_summary": "Mild risk-off session with semis under pressure ahead of NVDA earnings and geopolitical noise from Iran sanctions; S&P holding its uptrend but breadth is soft. My book is well-positioned with three profitable holdings and 60% cash — no need to force activity into a tape that isn't offering a clean setup.",
"risk_assessment": "Three positions, all green, all within size limits, cash at 60.5%. Biggest risk is SMCI's compliance headline drag — it's down 5.2% today and the Taiwan export story could escalate. ABT at RSI 75 is hot but the trend is strong and I'm not trimming a winner early given my track-record problem. No position is below its stop line.",
"decisions": [],
"watch_notes": "HOLD run — no clean entry in the affordable universe without chasing. SMCI: thesis intact while above 50-day (~$30.50); if the Taiwan export compliance story escalates or price closes below the 50-day, exit immediately. ABT: let it run toward +25% (~$123.76) before considering a trim; RSI 75 is hot but trend supports it. NU: hold unless it breaks below $13.80 (recent support area). HIMS ($30.94) is a potential mean-reversion candidate if it gets more oversold (RSI < 40) with a clearer catalyst — not there yet. Watching NVDA earnings as a directional catalyst for the entire semi complex including SMCI.",
"consult_request": null
}
```S&P and Nasdaq slipping as chip stocks drag, with yields declining and a rotation tone dominating. The tape is mildly risk-off but not de-risking — tech is under pressure while defensives hold. With 60% cash and three green positions, this is a tape to respect, not to chase.
Exposure is 39.6% across three positions, all in the green, with no position above the 15% cap. SMCI is the main risk: down 4.8% today on revived compliance/export concerns, which is a thesis-relevant headline. ABT is extended at RSI 78 but trend is intact. NU is stable. Overall book risk is moderate and manageable.
SMCI: watching for a break below its 50-day (~$30.60) as the compliance-news invalidation trigger; if it closes there, exit without hesitation. ABT: RSI 78 is extended — if it stalls or rolls over near $118-120, trim the single share to lock the +18% gain. NU: holding unless it breaks below $14.00. No new buys this run — the chip-slide tape and my own track record (cutting winners early, holding losers) argue for discipline over activity. Watching SLS as a potential pullback-buy in its strong uptrend if it stabilizes above $13.50 with volume, but ATR of 8.6% demands a very small size if I do enter.
{
"market_summary": "S&P and Nasdaq slipping as chip stocks drag, with yields declining and a rotation tone dominating. The tape is mildly risk-off but not de-risking — tech is under pressure while defensives hold. With 60% cash and three green positions, this is a tape to respect, not to chase.",
"risk_assessment": "Exposure is 39.6% across three positions, all in the green, with no position above the 15% cap. SMCI is the main risk: down 4.8% today on revived compliance/export concerns, which is a thesis-relevant headline. ABT is extended at RSI 78 but trend is intact. NU is stable. Overall book risk is moderate and manageable.",
"decisions": [],
"watch_notes": "SMCI: watching for a break below its 50-day (~$30.60) as the compliance-news invalidation trigger; if it closes there, exit without hesitation. ABT: RSI 78 is extended — if it stalls or rolls over near $118-120, trim the single share to lock the +18% gain. NU: holding unless it breaks below $14.00. No new buys this run — the chip-slide tape and my own track record (cutting winners early, holding losers) argue for discipline over activity. Watching SLS as a potential pullback-buy in its strong uptrend if it stabilizes above $13.50 with volume, but ATR of 8.6% demands a very small size if I do enter.",
"consult_request": null
}Mildly risk-off tape with semiconductors under pressure (SMCI -5.6%, MU -6.9%) and Nasdaq slipping on US-Canada trade tensions. S&P remains in an uptrend (1M +3.28%) so this is a tactical pullback, not a regime break — but it's not a tape to add risk aggressively.
Book is 50.8% exposed across four names, with NU and SMCI both near the 15% cap. The main risk is concentrated semiconductor exposure (SMCI) into a chip-sector slide, and WTTR has deteriorated past my -12% stop line with no technical recovery signal.
SMCI is my key watch — down 5.6% today and -8.2% on the week but still +12.8% from cost with uptrend intact. If it breaks below $30 (below my $31.17 cost and the 50d), I will cut. ABT at RSI 78 is extended but it's a low-ATR (2.2%) defensive name; trim consideration starts at +25% (~$123.50). NU remains constructive at +5.8%. Post-WTTR sale, cash will be ~$620 (60%+), giving me dry powder for a proper setup but no reason to force anything into this chip-heavy pullback.
{
"market_summary": "Mildly risk-off tape with semiconductors under pressure (SMCI -5.6%, MU -6.9%) and Nasdaq slipping on US-Canada trade tensions. S&P remains in an uptrend (1M +3.28%) so this is a tactical pullback, not a regime break — but it's not a tape to add risk aggressively.",
"risk_assessment": "Book is 50.8% exposed across four names, with NU and SMCI both near the 15% cap. The main risk is concentrated semiconductor exposure (SMCI) into a chip-sector slide, and WTTR has deteriorated past my -12% stop line with no technical recovery signal.",
"decisions": [
{
"action": "SELL",
"ticker": "WTTR",
"shares": 6,
"conviction": "MEDIUM",
"thesis": "Cut the loser: thesis was water-infrastructure growth but technicals have broken below 50d with a -10% weekly drop.",
"invalidation": "Already invalidated — stock is -13.3% from cost, below its 50-day MA, and the choppy trend gives no reversal signal despite positive Q2 earnings news.",
"reasoning": "WTTR crossed my -12% stop-review line and the technical picture has deteriorated meaningfully: -10.1% on the week, below the 50-day moving average, RSI at 44 with no oversold bounce forming. The fundamental thesis (Q2 revenue growth to $395.8M, net income climbing) is still intact, but the market is clearly not rewarding it — I can't defend a position where price action has diverged this far from the thesis execution. Volume is light (0.2x average) so there's no panic bottom to buy. Disciplined risk management says cut here and reallocate the capital rather than hope for a turnaround in a choppy name. The realized loss (~$17.64) is small relative to the portfolio and preserves capital for better setups."
}
],
"watch_notes": "SMCI is my key watch — down 5.6% today and -8.2% on the week but still +12.8% from cost with uptrend intact. If it breaks below $30 (below my $31.17 cost and the 50d), I will cut. ABT at RSI 78 is extended but it's a low-ATR (2.2%) defensive name; trim consideration starts at +25% (~$123.50). NU remains constructive at +5.8%. Post-WTTR sale, cash will be ~$620 (60%+), giving me dry powder for a proper setup but no reason to force anything into this chip-heavy pullback.",
"consult_request": null
}S&P futures are slightly lower as chip stocks slide ahead of Nvidia earnings and Jackson Hole; oil is dropping on Iran headlines. The tape is in a cautious rotation mode — tech under pressure, defensive and energy names mixed. This is not a tape to chase risk into; patience and position management take priority over new deployment.
Four positions, ~51% invested, 49% cash — well-balanced for this regime. Concentration risk is moderate with SMCI and NU both near 14%. The main vulnerability is WTTR at -10.81%, one bad session from the -12% stop-review line; ABT's RSI at 78 is a secondary overbought flag. No position is broken, but WTTR demands explicit attention.
WTTR: defending at current levels — thesis intact (Q2 revenue $395.8M, net income climbing, 100-mile pipeline deal announced), drop appears sector-driven not thesis-specific. Hard line: if WTTR closes below $19.00 (approx -14% from cost) or breaks its 50-day meaningfully, I exit without negotiation. ABT: watching RSI 78 — if it tags +25% ($124) I trim to lock gains. SMCI: holding through Nvidia earnings volatility; a close below $33 (below 50-day) would invalidate. NU: choppy but holding above 50-day; no action needed unless it breaks $13.50. No new buys this run — every affordable candidate on the gainer list is either RSI >70, at a 52-week high (DK, VIRT, CVI, NEXA), or up double digits today (IQMX, INFQ). Chasing into a cautious pre-event tape is exactly the failure mode I'm graded on avoiding.
{
"market_summary": "S&P futures are slightly lower as chip stocks slide ahead of Nvidia earnings and Jackson Hole; oil is dropping on Iran headlines. The tape is in a cautious rotation mode — tech under pressure, defensive and energy names mixed. This is not a tape to chase risk into; patience and position management take priority over new deployment.",
"risk_assessment": "Four positions, ~51% invested, 49% cash — well-balanced for this regime. Concentration risk is moderate with SMCI and NU both near 14%. The main vulnerability is WTTR at -10.81%, one bad session from the -12% stop-review line; ABT's RSI at 78 is a secondary overbought flag. No position is broken, but WTTR demands explicit attention.",
"decisions": [],
"watch_notes": "WTTR: defending at current levels — thesis intact (Q2 revenue $395.8M, net income climbing, 100-mile pipeline deal announced), drop appears sector-driven not thesis-specific. Hard line: if WTTR closes below $19.00 (approx -14% from cost) or breaks its 50-day meaningfully, I exit without negotiation. ABT: watching RSI 78 — if it tags +25% ($124) I trim to lock gains. SMCI: holding through Nvidia earnings volatility; a close below $33 (below 50-day) would invalidate. NU: choppy but holding above 50-day; no action needed unless it breaks $13.50. No new buys this run — every affordable candidate on the gainer list is either RSI >70, at a 52-week high (DK, VIRT, CVI, NEXA), or up double digits today (IQMX, INFQ). Chasing into a cautious pre-event tape is exactly the failure mode I'm graded on avoiding.",
"consult_request": null
}S&P remains in a strong uptrend but finished the week down 1.43% as surging bond yields rattled equities. Headlines are uniformly cautious-to-bearish (bubble warnings, 20% drop calls), which is noise at the margin but the yield move is real and warrants defensive sizing. This is a risk-on trend with accumulating headwinds — not the time to extend.
Book is 48.8% cash with 4 positions, none at the 15% cap, and only WTTR is underwater at -10.81% (approaching the -12% stop-review line but thesis intact). ABT and SMCI are extended but not yet at the +25% trim line. Concentration risk is low; the main threat is a yield-driven broad de-risking that would hit the momentum names hardest.
WTTR: defend at current levels — thesis intact (surging earnings estimates, new pipeline/storage contracts, above 50-day). Invalidation if it closes below the 50-day MA or hits -12% from cost (~$19.45). ABT: RSI 78 and +17.8% — approaching trim territory; if it stalls at this RSI next run, lock partial gains. SMCI: +19.5%, watch for export-probe headline risk; trim if it fails to hold $35. NU: choppy but earnings catalyst intact; hold. No new positions this run — every affordable candidate on the gainers list is extended (SLS, IQMX, HOOD, DK, VIRT all up double digits today with elevated RSI), and the yield regime argues for patience. Cash is a position here.
Market is closed — fills use the last available close.
{
"market_summary": "S&P remains in a strong uptrend but finished the week down 1.43% as surging bond yields rattled equities. Headlines are uniformly cautious-to-bearish (bubble warnings, 20% drop calls), which is noise at the margin but the yield move is real and warrants defensive sizing. This is a risk-on trend with accumulating headwinds — not the time to extend.",
"risk_assessment": "Book is 48.8% cash with 4 positions, none at the 15% cap, and only WTTR is underwater at -10.81% (approaching the -12% stop-review line but thesis intact). ABT and SMCI are extended but not yet at the +25% trim line. Concentration risk is low; the main threat is a yield-driven broad de-risking that would hit the momentum names hardest.",
"decisions": [],
"watch_notes": "WTTR: defend at current levels — thesis intact (surging earnings estimates, new pipeline/storage contracts, above 50-day). Invalidation if it closes below the 50-day MA or hits -12% from cost (~$19.45). ABT: RSI 78 and +17.8% — approaching trim territory; if it stalls at this RSI next run, lock partial gains. SMCI: +19.5%, watch for export-probe headline risk; trim if it fails to hold $35. NU: choppy but earnings catalyst intact; hold. No new positions this run — every affordable candidate on the gainers list is extended (SLS, IQMX, HOOD, DK, VIRT all up double digits today with elevated RSI), and the yield regime argues for patience. Cash is a position here.",
"consult_request": null
}orphaned — service restarted mid-run, never resolved